U.S. Rep. Morgan Griffith (R-VA) and Rep. Angie Craig (D-MN) have reintroduced two bills in the U.S. House that would require the Food and Drug Administration to regulate hemp-derived CBD.

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 would subject hemp extract products to the regulatory framework for dietary supplements. Originally introduced in the House of Representatives in February 2021, it failed to leave the Energy and Commerce subcommittee on Health.